Study details
Enrolling now
The Choice of Vasopressor to Prevent Postoperative Acute Kidney Injury After Major Non-Cardiac Surgery
University of California, San Francisco
NCT IDNCT06802224ClinicalTrials.gov data as of Apr 2026
Phase
Phase 4
Target enrollment
18,000
Study length
about 3.3 years
Ages
18+
Locations
8 sites in CA, MD, MI +3
About this study
This trial is testing whether norepinephrine or phenylephrine is better at preventing kidney injury after major surgery. The goal is to determine which vasopressor medication is more effective in protecting the kidneys and other organs during surgery.
Based on ClinicalTrials.gov records.
What participants do
- 1.Take Norepinephrine
- 2.Take Phenylephrine
PhasePhase 4
DrugNorepinephrine
Routeinjection
Participation effort
Estimated from trial records. Details can vary by site.
Time + visits
Low10%
Logistics
Moderate50%
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
Drug classes
norepinephrine, phenylephrine
Drug routes
injection (Injection), ocular (Ophthalmic Solution)
Body systems
Renal, Cardiology / Heart